about
Targeting von Willebrand factor and platelet glycoprotein Ib receptor.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report.Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndromeRole of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studiesDeficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.Malignant Hypertension and Thrombotic Thrombocytopenic Purpura: False Friends.The global aHUS registry: methodology and initial patient characteristics.Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner.The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.Emergency management of hypertension in children.The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activationCyclophosphamide-associated cardiotoxicity in a child after stem cell transplantation for β-thalassemia major: case report and review of the literature.Interference with Gsα-Coupled Receptor Signaling in Renin-Producing Cells Leads to Renal Endothelial Damage.Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.Complement in Kidney TransplantationCase report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.Fascinating interaction between host and pathogen.Scleroderma Renal Crisis in a Normotensive Patient.tHe USual Suspects.
P2860
Q33392975-0589FFAF-8627-4DFE-9924-CA3616222291Q33394010-4344BAAB-7DF3-4DB7-BD85-2A97E0859324Q33398967-E26E12BF-C35E-4A5D-9C2B-CA88C98C54B3Q33401182-237C6E69-A5EC-4E2B-ABDF-C79D1494B886Q33401572-FD48BAF5-E24D-4330-9852-D0EDC1C32C2EQ33409878-92F81D3F-ECD2-4BDC-9CDF-46C7CE20AC37Q33410829-D17FB746-5171-41F3-A134-E0CAE83B2196Q33420172-D86B3E9C-DD7A-48A3-8BDD-504883E5047FQ33422493-E9D04951-619F-4439-94CB-7687F3FD9ECAQ33423118-D01D5E48-AA10-4E59-8BBC-5AEAC431B2F1Q33423695-06ACA994-9456-41C1-B6CF-CD1989EC5503Q33428291-26BC0318-A457-4570-9871-ABC9D5FDD9ADQ33428410-3DDB9CB9-9F7C-4CF0-B621-E7C00226A9D8Q33431097-FEDB153B-E337-4373-A19C-8D1A05462545Q34545939-C5CB6660-9988-4902-9C86-33719EA19C6FQ35936641-2F0196FC-BC2F-46FB-8A37-13E8BDA73AADQ36643354-1E51D439-E6D9-4725-B74F-8EB56D9EC395Q38154349-3145C37D-C38C-41C0-BA93-779986BD75C5Q38642440-FC745536-974D-464F-B287-955F7EA9987CQ38862309-61FBA993-3B69-4A94-AB19-95B753D561DDQ39371134-5608C84B-6DBD-49AD-9BC4-3D46650F6324Q43213346-F4776499-38BB-4B65-87AF-67A1246D3DAAQ45434695-B02E6A97-7D26-4F43-AB33-FFCBF4647896Q49409192-7C10079C-F905-4A02-B689-035C98CE97F8Q54356064-718DA3E6-F089-4741-BAB3-792B4219DE69
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Thrombotic microangiopathy: new insights
@ast
Thrombotic microangiopathy: new insights
@en
Thrombotic microangiopathy: new insights
@nl
type
label
Thrombotic microangiopathy: new insights
@ast
Thrombotic microangiopathy: new insights
@en
Thrombotic microangiopathy: new insights
@nl
prefLabel
Thrombotic microangiopathy: new insights
@ast
Thrombotic microangiopathy: new insights
@en
Thrombotic microangiopathy: new insights
@nl
P1476
Thrombotic microangiopathy: new insights
@en
P2093
Kerstin Amann
Kerstin Benz
P356
10.1097/MNH.0B013E3283378F25
P407
P577
2010-05-01T00:00:00Z